Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q3 2023
Institutional positions in Aligos Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −5 vs. Q2 2023
- Shares held
- 25.7M
- −554.6K (−2.1%) vs. Q2 2023
- Total value
- $19.2M
- −$6.30M (−24.7%) vs. Q2 2023
- New holders
- 2
- 3 more added
- Sold out
- 7
- 10 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 2 | $1 | 0.00% | +2 | New |
| Newbridge Financial Services Group, Inc. | 37 | $28 | 0.00% | 00.0% | Unchanged |
| ZRC Wealth Management, LLC | 100 | $75 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 195 | $146 | 0.00% | −3−1.5% | Reduced |
| Federated Hermes, Inc. | 653 | $488 | 0.00% | −970−59.8% | Reduced |
| JPMorgan Chase & Co | 677 | $506 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1,200 | $896 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,000 | $1.49K | 0.00% | −1,000−33.3% | Reduced |
| UBS Group AG | 5,432 | $4.06K | 0.00% | +5,319+4,707.1% | Added |
| Creative Planning | 10,050 | $7.51K | 0.00% | +10,050 | New |
| CWM, LLC | 16,891 | $13.0K | 0.00% | 00.0% | Unchanged |
| HarbourVest Partners LLC | 18,783 | $14.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 22,924 | $17.1K | 0.00% | −6,259−21.4% | Reduced |
| Choate Investment Advisors | 24,000 | $17.9K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 31,383 | $23.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 39,351 | $29.4K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 91,807 | $68.6K | 0.00% | −84,068−47.8% | Reduced |
| Bridgeway Capital Management, LLC | 92,000 | $68.7K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 97,423 | $72.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 241,503 | $180.5K | 0.00% | −15,089−5.9% | Reduced |
| BlackRock Inc. | 296,959 | $221.8K | 0.00% | −3,504−1.2% | Reduced |
| Renaissance Technologies LLC | 321,360 | $240.0K | 0.00% | −109,195−25.4% | Reduced |
| Acadian Asset Management LLC | 564,715 | $420.0K | 0.00% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 631,887 | $472.0K | 0.18% | 00.0% | Unchanged |
| Royal Bank of Canada | 644,553 | $481.0K | 0.00% | −195,840−23.3% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $555.2K | 0.22% | 00.0% | Unchanged |
| Newtyn Management, LLC | 920,000 | $687.2K | 0.17% | +20,000+2.2% | Added |
| Vanguard Group Inc | 1,010,617 | $754.9K | 0.00% | +15,905+1.6% | Added |
| Bank of America Corp | 1,150,227 | $859.2K | 0.00% | −718−0.1% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,223,278 | $913.8K | 0.00% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,076,400 | $1.55M | 0.01% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 2,309,764 | $1.73M | 0.04% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 2,320,381 | $1.73M | 0.92% | 00.0% | Unchanged |
| Tang Capital Management LLC | 3,329,048 | $2.49M | 0.35% | 00.0% | Unchanged |
| Vivo Capital, LLC | 3,547,030 | $2.65M | 0.33% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 3,948,360 | $2.95M | 0.10% | 00.0% | Unchanged |
| Deutsche Bank AG | 0 | $0 | 0.00% | −71,290−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −52,400−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −27,859−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −18,353−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,105−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,189−100.0% | Sold out |